Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2008
02/28/2008US20080050824 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use
02/28/2008US20080050823 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use
02/28/2008US20080050822 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use
02/28/2008US20080050820 Casein kinase stress-related polypeptides and methods of use in plants
02/28/2008US20080050819 Constructs for Marker Excision Based on Dual-Function Selection Marker
02/28/2008US20080050818 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use
02/28/2008US20080050811 Testicular carnitine transporter and its gene
02/28/2008US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
02/28/2008US20080050809 Novel human kinases and polynucleotides encoding the same
02/28/2008US20080050807 Gene encoding alkaline liquefying alpha-amylase
02/28/2008US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture
02/28/2008US20080050791 Pufa polyketide synthase systems and uses thereof
02/28/2008US20080050790 Pufa polyketide synthase systems and uses thereof
02/28/2008US20080050776 Stable mutated pro nerve growth factors
02/28/2008US20080050774 Computer-based system for monitoring differential expression; host cells
02/28/2008US20080050759 Screening Assay for Anti-Bacterial Compounds
02/28/2008US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection
02/28/2008US20080050745 Sugar chain synthesizing agent having beta1,3-N-acetyglucosaminyltransferase activity
02/28/2008US20080050742 Methods and Reagents for Combined PCR Amplification
02/28/2008US20080050741 Messenger RNA Profiling: Body Fluid Identification Using Multiplex Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
02/28/2008US20080050738 Detection of target nucleic acid
02/28/2008US20080050728 suppressing non-specific cross-hybridization between repetitive elements present in nucleic acid probes and corresponding repetitive elements in the target nucleic acid by using DNA synthesized to contain a plurality of repetitive elements while avoiding low and single copy sequences
02/28/2008US20080050726 Methods for diagnosing pancreatic cancer
02/28/2008US20080050718 Methods, Articles, and Compositions for Identifying Oligonucleotides
02/28/2008US20080050505 Phosphopantetheinyl transferases from bacteria
02/28/2008US20080050460 Uses of lectin-conotoxin
02/28/2008US20080050406 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies
02/28/2008US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection
02/28/2008US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits
02/28/2008US20080050393 Novel nucleic acids and polypeptides
02/28/2008US20080050386 Novel proteins, gene encoding the same and method of utilization thereof
02/28/2008US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells
02/28/2008US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors
02/28/2008US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism
02/28/2008US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder
02/28/2008US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
02/28/2008US20080050310 Antibodies and immunoconjugates and uses therefor
02/28/2008CA2661765A1 Antisense composition and method for inhibition of mirna biogenesis
02/28/2008CA2661292A1 Compositions and methods for treating myelosuppression
02/28/2008CA2643356A1 Synthetic genomes
02/27/2008EP1892299A2 Sense mRNA therapy
02/27/2008EP1892298A1 Streptococcal C5a peptidase vaccine
02/27/2008EP1891438A2 Methods for identifying ligands for stem cells and cells derived therefrom
02/27/2008EP1891238A2 Method for breast cancer diagnosis/prognosis
02/27/2008EP1890711A1 Compounds for treating or preventing amine oxidase related diseases or disorders
02/27/2008EP1890708A1 Glucose inducible insulin expression and methods of treating diabetes
02/27/2008EP1789578A4 Cleavable solid phases for isolating nucleic acids
02/27/2008EP1587412A4 Methods of detecting gene expression in normal and cancerous cells
02/27/2008EP1567540A4 Cftr allele detection assays
02/27/2008EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors
02/27/2008EP0739350B1 Ligand that binds fas antigen
02/27/2008CN101133166A Making nucleic acid sequences in parallel and use
02/27/2008CN101133074A RNAi modulation of APOB and uses thereof
02/27/2008CN101133073A Synthesis of oligonucleotides
02/27/2008CN101130784A Method for altering plant flower organ morphology and its special expression vector
02/27/2008CN101130776A Pig carcass character GFAT1 gene clone and its application
02/27/2008CN101130774A Nucleotide molecule SR5B and its application in preparation of antidiabetic medicine
02/27/2008CN101130773A Nucleotide molecule SR5B2 and its application in preparation of antidiabetic medicine
02/27/2008CN101130772A Nucleotide molecule SR4B2 and its application in preparation of antidiabetic medicine
02/27/2008CN101130771A Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament
02/27/2008CN101130770A Nucleotide molecule SR2B and application of the same in producing antidiabetic medicament
02/27/2008CN101130769A Nucleotide molecule SR4B and application of the same in producing antidiabetic medicament
02/27/2008CN101130768A Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament
02/27/2008CN101130762A Efficient bacillus thuringiensis cry8H gene, protein for vaginata destructive insect and uses of the same
02/27/2008CN101130565A Nucleotide molecule SR3B and application of the same in producing antidiabetic medicament
02/27/2008CN101130564A Nucleotide molecule SR2B2 and application of the same in producing antidiabetic medicament
02/27/2008CN101130563A Nucleotide molecule SR1B2 and application of the same in producing antidiabetic medicament
02/27/2008CN100371444C VEGF expression-inhibiting siRNA and application thereof
02/27/2008CN100371441C Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens
02/27/2008CN100371343C Molecule marking method for discriminating cytoplasmic male sterile gene of leaf mustard
02/27/2008CN100371342C Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method
02/26/2008US7335813 Comprising transcription regulating nucleotide sequences with guard cell-preferential or guard cell-specific expression profiles in plants obtainable from Arabidopsis thaliana gene At5g58580, or from Arabidopsis genomic DNA sequences as described in patent
02/26/2008US7335765 Nucleoside and oligonucleotide analogues
02/26/2008US7335764 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding acyl CoA cholesterol acyltransferase-2 that hybridizes with and inhibits the expression; treating atherosclerosis, cardiovascular disorders or metabolism disorders
02/26/2008US7335763 A ribozyme-resistant cell for producing a HSV expression vector encoding an anti-HSV ribozyme; comprising at least one nucleotide sequence encoding a portion of an HSV gene, having been modified to not be cleavable by ribozyme; Hammerhead ribozymes
02/26/2008US7335762 Cuvette for use in the concurrent monitoring, recording and analysis of lignt emission in microarrays
02/26/2008US7335761 Expression vector comprising regulatory sequences associated with tissue specific expression of ovomucoid gene for use as a gene expression control elements in heterologous gene transfer and transcription in birds
02/26/2008US7335759 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides
02/26/2008US7335757 Carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same
02/26/2008US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer
02/26/2008US7335755 Nucleic acids isolated in neuroblastoma
02/26/2008US7335754 Ehrlichia canis genes and vaccines
02/26/2008US7335750 Hybrid compositions for intracellular targeting
02/26/2008US7335748 RG1 antibodies and uses thereof
02/26/2008US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
02/26/2008US7335745 Vectors with DNA encoding pro polypeptides
02/26/2008US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders
02/26/2008US7335738 Heregulin-like factor
02/26/2008US7335735 Intracellular estradiol binding protein (IEBP) for use as tool in identifying modulator for treatment and prevention of bone and cell proliferative disorders
02/26/2008US7335732 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
02/26/2008US7335731 PRO4332 polypeptides
02/26/2008US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
02/26/2008US7335729 PRO4320 polypeptide
02/26/2008US7335647 Drugs for liver diseases
02/26/2008US7335506 Trangenic methylobacillus which has enhanced production of lysine and arginine for use in medicine, animal feeds and cosmetics
02/26/2008US7335504 Engineered enzymes and uses thereof
02/26/2008US7335503 Fermentation medium comprising a granular starch hydrolyzing enzyme having glucoamylase activity (GSHE) produced from a culture of Trichoderma reesei
02/26/2008US7335502 Protein comprising an amino acid sequence having a chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase activity; stereoselectivity ; can produce an optically active compound with an industrial scale by using microorganisms with the gene
02/26/2008US7335501 Derived from fungi of the Penicillium genus; vectors and transformed host organisms containing these polynucleotides encoding the phytases
02/26/2008US7335499 tRNA synthetase